相关实验视频

Updated: Jul 4, 2025

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles

Published on: December 1, 2016

线粒体向和氧气自给自足的奇特空心纳米平台用于增强乳腺癌光动力学治疗

Jing Li¹, Yu Wang¹, Jun Tao¹

¹Key Laboratory for Organic Electronics & Information Displays and Jiangsu Key Laboratory for Biosensors, Institute of Advanced Materials, Jiangsu National Synergetic Innovation Centre for Advanced Materials, Nanjing University of Posts and Telecommunications, Nanjing 210023, China.

Bioinorganic chemistry and applications

|February 9, 2024

概括

这项研究开发了用于光动力学治疗 (PDT) 的新型纳米粒子,以增强癌症治疗. 这些向的纳米粒子改善了光敏剂的传递,并减轻了瘤缺氧,显著提高了对三阴性乳腺癌的治疗效果.

科学领域:

生物医学工程生物医学工程
纳米技术纳米技术
在瘤学瘤学.

背景情况:

光动力疗法 (PDT) 提供了微创性瘤治疗,但面临着光敏剂向和瘤缺氧的挑战.
药物输送不良和缺氧瘤微环境限制了传统PDT策略的有效性.

研究的目的:

为增强PDT开发一个古怪的空心半孔有机二氧化纳米粒子 (EHMON) 平台.
设计一个具有针对线粒体和减轻缺氧能力的纳米平台,用于三阴性乳腺癌治疗.

主要方法:

合成的EHMON具有特定的结构性质 (奇特的空心,中孔通道).
经过修改的EHMONs具有向线粒体的分子 (CTPP) 和光敏感剂 (Ce6).
装载的携带氧气的 perfluorocarbons (PFCs) 进入纳米粒子腔.

主要成果:

EHMONs-Ce6-CTPP表现出极好的生物相容性,并向癌细胞中的线粒体.
EHMONs-Ce6-CTPP@PFCs的携带氧的能力有效地缓解了瘤缺氧.
观察到反应性氧物种 (ROSs) 的增强产生以及对三阴性乳腺癌的优越体外/体内治疗效果.

结论:

开发的EHMONs-Ce6-CTPP@PFCs纳米平台显示了提高PDT疗效的巨大潜力.
这种有针对性的,携带氧气的策略为克服当前光动力学癌症治疗的局限性提供了一个有希望的方法.

更多相关视频

An In-House-Built and Light-Emitting-Diode-Based Photodynamic Therapy Device for Enhancing Verteporfin Cytotoxicity in a 2D Cell Culture Model

An In-House-Built and Light-Emitting-Diode-Based Photodynamic Therapy Device for Enhancing Verteporfin Cytotoxicity in a 2D Cell Culture Model

Published on: January 13, 2023

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy

Published on: May 22, 2020

相关概念视频

Electron Transport Chain: Complex I and II

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...